TrialDermatology (Basel, Switzerland)2025

Efficacy and Safety of Upadacitinib versus Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Four Body Regions: Analysis from the Heads Up Study.

Jacob P Thyssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.